13F HOLDINGS REPORT
Sarissa Capital Management LP
Quarter ended Q2 2025 · Filed August 14, 2025 · Accession 0000899140-25-000986
Total Value
$154.4M
Positions
7
Other Managers
0
Confidential Omitted
No
Holdings (7)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | INNOVIVA INC | INVA | 2,816,022 | $56.6M | 36.64% |
| 2 | NEUROCRINE BIOSCIENCES INC | NBIX | 303,151 | $38.1M | 24.68% |
| 3 | AMARIN CORP PLC | AMRN | 1,242,527 | $20.2M | 13.05% |
| 4 | CYTOKINETICS INC | CYTK | 588,357 | $19.4M | 12.59% |
| 5 | IRONWOOD PHARMACEUTICALS INC | IRWD | 15,919,435 | $11.4M | 7.40% |
| 6 | LANTHEUS HLDGS INC | LNTH | 96,251 | $7.9M | 5.10% |
| 7 | VOR BIOPHARMA INC | VOR | 508,016 | $822,986 | 0.53% |